TGFB1 and diabetic retinopathy: Chebulagic acid and chebulinic acid were demonstrated to inhibit TGF-β1 induced fibrotic changes in the chorio-retinal endothelial cells and as potential adjuvants in the management of diabetic retinopathy [76].